Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal Antibody against CD19 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-172 amino acids from the N-terminal region of human CD19. |
BLK Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This BLK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BLK. |
P2Y9 (LPAR4) (Center) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human |
| Immunogen | KLH conjugated synthetic peptide between 127-156 amino acids from the Central region of human P2RY9 / LPAR4 |
Rabbit Polyclonal Antibody against PYGM (C-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PYGM antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 698-727 amino acids from the C-terminal region of human PYGM. |
Rabbit Polyclonal Antibody against CDH3 (C-term)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CDH3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 660-688 amino acids from the C-terminal region of human CDH3. |
Rabbit Polyclonal Antibody against BCL2L2
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This Bcl antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 24-59 amino acids from human Bcl. |
Rabbit Polyclonal Antibody against PIK3CA (Center)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PI3KCA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 504-533 amino acids from the Central region of human PI3KCA. |
Rabbit Polyclonal Antibody against TRPM8 (Center R536)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This TRPM8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 521-552 amino acids from the Central region of human TRPM8. |
Rabbit Polyclonal Antibody against PHPT1 (C-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PHPT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 88-117 amino acids from the C-terminal region of human PHPT1. |
Rabbit Polyclonal Antibody against OPRS1 (N-term)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This OPRS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 47-81 amino acids from the N-terminal region of human OPRS1. |
Rabbit Polyclonal Antibody against RAC1 (S71)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This RAC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 49-78 amino acids from human RAC1. |
Rabbit Polyclonal Antibody against CD8A (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD8A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 59-88 amino acids from the N-terminal region of human CD8A. |
Rabbit polyclonal anti-POLR2C antibody (C-term)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This POLR2C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-228 amino acids from the C-terminal region of human POLR2C. |
USD 450.00
2 Weeks
Active filters
Filter by
Target Symbol
Reactivities
Antibody Hosts
Clonalities
Conjugates
Pathways
- T cell receptor signaling pathway (4)
- B cell receptor signaling pathway (3)
- Cell adhesion molecules (CAMs) (3)
- Colorectal cancer (3)
- Focal adhesion (3)
- Leukocyte transendothelial migration (3)
- Pathways in cancer (3)
- Adherens junction (2)
- Autoimmune thyroid disease (2)
- Axon guidance (2)
- Chemokine signaling pathway (2)
- Endometrial cancer (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Hematopoietic cell lineage (2)
- Insulin signaling pathway (2)
- Jak-STAT signaling pathway (2)
- Metabolic pathways (2)
- Natural killer cell mediated cytotoxicity (2)
- Neuroactive ligand-receptor interaction (2)
- Neurotrophin signaling pathway (2)
- Pancreatic cancer (2)
- Primary immunodeficiency (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Renal cell carcinoma (2)
- Toll-like receptor signaling pathway (2)
- VEGF signaling pathway (2)
- Wnt signaling pathway (2)
- Acute myeloid leukemia (1)
- Allograft rejection (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Antigen processing and presentation (1)
- Apoptosis (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Asthma (1)
- Basal cell carcinoma (1)
- Chronic myeloid leukemia (1)
- Cytokine-cytokine receptor interaction (1)
- ECM-receptor interaction (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- ErbB signaling pathway (1)
- Fructose and mannose metabolism (1)
- Glioma (1)
- Huntington's disease (1)
- Inositol phosphate metabolism (1)
- MAPK signaling pathway (1)
- Melanogenesis (1)
- Melanoma (1)
- Non-small cell lung cancer (1)
- Pathogenic Escherichia coli infection (1)
- Phosphatidylinositol signaling system (1)
- Progesterone-mediated oocyte maturation (1)
- Purine metabolism (1)
- Pyrimidine metabolism (1)
- RNA polymerase (1)
- Riboflavin metabolism (1)
- Small cell lung cancer (1)
- Starch and sucrose metabolism (1)
- Systemic lupus erythematosus (1)
- Thiamine metabolism (1)
- Thyroid cancer (1)
- Tight junction (1)
- Type II diabetes mellitus (1)
- Viral myocarditis (1)
- mTOR signaling pathway (1)